Faeth Therapeutics, Inc. (FTH)
8.43
-0.26
(-2.99%)
USD |
NASDAQ |
Nov 20, 12:13
Faeth Therapeutics Free Cash Flow : -43.28M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -43.28M |
| June 30, 2026 | -33.86M |
| March 31, 2026 | -24.11M |
| December 31, 2025 | -20.47M |
| September 30, 2025 | -22.40M |
| June 30, 2025 | -24.28M |
| March 31, 2025 | -24.26M |
| December 31, 2024 | -24.82M |
| September 30, 2024 | -25.19M |
| June 30, 2024 | -24.38M |
| Date | Value |
|---|---|
| March 31, 2024 | -27.97M |
| December 31, 2023 | -32.20M |
| September 30, 2023 | -35.61M |
| June 30, 2023 | -38.01M |
| March 31, 2023 | -40.46M |
| December 31, 2022 | -39.35M |
| September 30, 2022 | -38.18M |
| June 30, 2022 | -37.09M |
| March 31, 2022 | -31.80M |
| December 31, 2021 | -32.28M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cypherpunk Technologies, Inc. | -132.19M |
| Zymeworks, Inc. | -111.61M |
| Rhythm Pharmaceuticals, Inc. | -83.24M |
| Cue Biopharma, Inc. | -51.22M |
| Yarrow Bioscience, Inc. | -99.79M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.00M |
| Cash from Investing (Quarterly) | 0.175M |
| Cash from Financing (Quarterly) | 0.104M |
| Free Cash Flow Per Share (Quarterly) | -0.5033 |
| Free Cash Flow to Equity (Quarterly) | -12.56M |
| Free Cash Flow to Firm (Quarterly) | -13.00M |
| Free Cash Flow Yield | -19.87% |